Richard Christopher

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Kelowna, British Columbia, Canada
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/Richard Christopher/
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Richard Christopher

Form 4 holding Chief Executive Officer, Director

Lexaria Bioscience Corp.

Security class
Stock Options
Shares / value
350,000
Estimated value
$304,500
Report date
29 Jul 2025
Price
$0.8700
Ownership
Direct
Underlying class
Common Shares
Underlying amount
350,000
Form 4 holding Chief Financial Officer

INVIVO THERAPEUTICS HOLDINGS CORP.

Security class
Stock Option (right to buy)
Shares / value
20,800
Estimated value
Report date
17 Nov 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Richard Christopher

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .